Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC

Clinical trial NCT01379521 · TERMINATED

Trial details

NCT number: NCT01379521
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2011-06-01
Primary completion: 2015-06-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.